Clinical Trials Browser

NETWORK × Interventional × Endometrial Hyperplasia × Clear all

NCT00892866 2024-05-03

CA-IX, p16, Proliferative Markers, and HPV in Diagnosing Cervical Lesions in Patients With Abnormal Cervical Cells

Phase NA Active not recruiting

Uterine Cervical Dysplasia, Endometrial Hyperplasia, Papillomavirus Infections